In an upland village in Tanay, Rizal, children would trek for up to one hour before sunrise just to make it to class. Many from poor and indigenous families, theseIn an upland village in Tanay, Rizal, children would trek for up to one hour before sunrise just to make it to class. Many from poor and indigenous families, these

Puregold’s ‘Pusong Panalo’ brightens students’ path in remote Rizal village

In an upland village in Tanay, Rizal, children would trek for up to one hour before sunrise just to make it to class. Many from poor and indigenous families, these students have no choice but to walk just to get an education.

To help make their daily trek safer and their school days brighter, leading supermarket chain Puregold Price Club, Inc. recently brought a comprehensive support package for Alas-Asin Elementary school.

The company’s support includes a reliable power source through solar panels, health and dental checkups, and essential goods, including school supplies for students and grocery packs for families. It also built a new playground, giving the community’s children a well-equipped space for play.

To support teachers and learners’ families, Puregold also delivered livelihood packages to provide them with new means to earn a living.

Ang ganda ng lente ng Puregold, nakita kami. Sobrang liwanag, nakita ‘yung pangangailangan ng school,” according to school head Marvie Guinto. “Although green ang kulay niyo, ginintuan ang puso ng mga staff.”

She noted how Puregold’s gift bags were packed with goodies that many of the children had never even seen or tried before.

Sobrang saya po kasi po kami ang napili ng Puregold at nabigyan po kami ng pagkain, drinks, at snacks, mga chocolate po, tsinelas at damit,” said one of the beneficiary students.

“‘Yung mga blessings nila, sobra na. ‘Yung dala nila masyadong madami. Thank you po Puregold sa mga biyaya na binigay niyo sa amin,” another student said.

Alas-Asin was the sixth school to benefit from Puregold’s “Pusong Panalo” program in 2025, as the top retailer sustained its program that aims to bridge the gap between urban and rural areas by providing much needed aid to overlooked communities.

The program, which started in 2024, has reached eight schools across the country so far, with the goal of providing urgent support, including learning technology, essential goods, classroom renovations, and solar panel installations for 30 more schools by 2028.

“Puregold believes that education is the key to a better life. For these children, this school represents their hope for a brighter future. We came here to provide better tools and facilities so these students can achieve their dreams,” said Puregold President Vincent Co.

Puregold believes that every Filipino child with a “gintong pangarap” deserves a fighting chance. Its Pusong Panalo program is looking for more schools to help.

If you know of a school in a remote or underserved area that needs a helping hand, you may reach out to Puregold through the following channels.

Facebook: Message the official Puregold Page

Email: alingpuring@puregold.com.ph

Mail: Puregold Price Club Inc., 900 D. Romualdez St., Paco, Manila, 1007


Spotlight is BusinessWorld’s sponsored section that allows advertisers to amplify their brand and connect with BusinessWorld’s audience by publishing their stories on the BusinessWorld Web site. For more information, send an email to online@bworldonline.com.

Join us on Viber at https://bit.ly/3hv6bLA to get more updates and subscribe to BusinessWorld’s titles and get exclusive content through www.bworld-x.com.

Market Opportunity
Sunrise Layer Logo
Sunrise Layer Price(SUNRISE)
$0.003573
$0.003573$0.003573
-0.86%
USD
Sunrise Layer (SUNRISE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26